Super Micro Computer, Inc. (SMCI): Nasdaq/NYSE listing notice — Super Micro cures Nasdaq audit committee deficiency by appointing Blair and Lin

Super Micro Computer, Inc.

Received Nasdaq notice on May 3 for failing audit committee independence rule after Fred Chan's resignation.
On May 9, appointed directors Robert Blair and Judy Lin to the audit committee, within the cure period.
Audit Committee now consists of four independent directors: Tally Liu, Dan Fairfax, Robert Blair, Judy Lin.
Company regained compliance with Nasdaq Listing Rule 5605(c)(2)(A).

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Super Micro Computer, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A)

Exact text from the filing

May 3, 2024, Super Micro Computer, Inc. (the “Company”) received a notice of deficiency (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) regarding the Company’s noncompliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires, among other things, that the audit committee (the “Audit Committee”) of the Company’s board of directors (the “Board”) be comprised of three independent directors. The deficiency cited in the Notice is the result of the previously announced resignation of Mr. Shiu Leung (Fred) Chan from the Board and the Audit Committee. On May 9, 2024, which was within the cur

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Super Micro Computer, Inc. filing history →

Source: SEC EDGAR

accession 0001375365-24-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.